DIN 02523310 — KETOROLAC TROMETHAMINE INJECTION USP 30 MG
KETOROLAC TROMETHAMINE INJECTION USP is a solution of Ketorolac tromethamine marketed by JAMP PHARMA CORPORATION. The full Ketorolac tromethamine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02523310
- Brand name
- KETOROLAC TROMETHAMINE INJECTION USP
- Active ingredient
- Ketorolac tromethamine
- Strength
- 30 MG
- Dosage form
- SOLUTION
- Route
- INTRAMUSCULAR
- Manufacturer
- JAMP PHARMA CORPORATION
- Health Canada status
- DORMANT
- Drug class
- Non-steroidal anti-inflammatory drug (NSAID)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Ketorolac tromethamine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 01968300 | ACULAR | 0.5 % | SOLUTION | ABBVIE CORPORATION | MARKETED |
| 02369362 | ACUVAIL | 0.45 % | SOLUTION | ABBVIE CORPORATION | MARKETED |
| 02229080 | APO-KETOROLAC | 10 MG | TABLET | APOTEX INC | MARKETED |
| 02243989 | APO-KETOROLAC INJECTABLE | 30 MG | SOLUTION | APOTEX INC | DORMANT |
| 02510855 | JAMP KETOROLAC | 10 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |
| 02245821 | KETOROLAC | 0.5 % | SOLUTION | AA PHARMA INC | MARKETED |
| 02244947 | KETOROLAC TROMETHAMINE INJECTION, USP | 30 MG | LIQUID | FRESENIUS KABI CANADA LTD | MARKETED |
| 02443376 | KETOROLAC TROMETHAMINE INJECTION, USP | 30 MG | SOLUTION | JUNO PHARMA CANADA INC. | MARKETED |
| 02465124 | MAR-KETOROLAC | 10 MG | TABLET | MARCAN PHARMACEUTICALS INC | MARKETED |
| 02461455 | MINT-KETOROLAC | 10 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED |
| 02162660 | TORADOL | 10 MG | TABLET | AA PHARMA INC | MARKETED |
| 02162644 | TORADOL IM | 10 MG | SOLUTION | ATNAHS PHARMA UK LIMITED | MARKETED |